Bellerophon Therapeutics, Inc.
BLPH
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.38M | 10.58M | 15.17M | 6.92M | 11.32M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 489.00K | 563.00K | 194.00K | 234.00K | 338.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 108.00K | 107.00K | 405.00K | 405.00K | 404.00K |
| Total Current Assets | 4.98M | 11.25M | 15.77M | 7.56M | 12.06M |
|
|
|||||
| Total Current Assets | 4.98M | 11.25M | 15.77M | 7.56M | 12.06M |
| Net Property, Plant & Equipment | -- | -- | 9.00K | 186.00K | 363.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 186.00K | 186.00K | 186.00K |
| Total Assets | 4.98M | 11.25M | 15.97M | 7.94M | 12.61M |
|
|
|||||
| Total Accounts Payable | 612.00K | 1.89M | 1.07M | 1.23M | 1.53M |
| Total Accrued Expenses | 644.00K | 3.74M | 4.29M | 3.97M | 3.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 8.00K | 203.00K | 396.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.26M | 5.62M | 5.36M | 5.40M | 5.18M |
|
|
|||||
| Total Current Liabilities | 1.26M | 5.62M | 5.36M | 5.40M | 5.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1.00K |
| Total Liabilities | 1.26M | 5.62M | 5.36M | 5.40M | 5.18M |
|
|
|||||
| Common Stock & APIC | 260.04M | 260.02M | 259.86M | 254.61M | 254.49M |
| Retained Earnings | -256.32M | -254.39M | -249.26M | -252.08M | -247.06M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.72M | 5.62M | 10.60M | 2.53M | 7.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.72M | 5.62M | 10.60M | 2.53M | 7.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.72M | 5.62M | 10.60M | 2.53M | 7.43M |
|
|
|||||
